^
    5ms
    A Study of EP0031-101 in Patients With Advanced RET-altered Malignancies (clinicaltrials.gov)
    P1/2, N=265, Recruiting, Ellipses Pharma
    Trial completion date • Trial primary completion date • Metastases
    |
    EP0031